StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Other Intangible Assets by Year

Other Intangible Assets — Total Accumulated Amortization ($M) ($M)

Amgen Other Intangible Assets: $32,784M in FY2025, up 15.3% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
32,784
Period ended Dec 31, 2025
Change on a year earlier
+15.3%
28,423 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Goodwill and Other Intangible Assets Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Intangible Assets — Total Accumulated Amortization ($M) ($M)Year on yearSource
FY2025Dec 31, 202532,784+15.3%Form 10-Q (filed 2026-08-05) ↗
FY2024Dec 31, 202428,423+19.4%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 202323,806+16.0%Form 10-K (filed 2025-02-14) ↗
FY2022Dec 31, 202220,525+14.1%Form 10-K (filed 2024-02-14) ↗
FY2021Dec 31, 202117,987+16.3%Form 10-K (filed 2023-02-09) ↗
FY2020Dec 31, 202015,461+22.4%Form 10-K (filed 2022-02-16) ↗
FY2019Dec 31, 201912,632+10.8%Form 10-Q (filed 2020-05-01) ↗
FY2018Dec 31, 201811,402+12.7%Form 10-Q (filed 2019-10-30) ↗
FY2017Dec 31, 201710,121+15.7%Form 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 20168,744+20.1%Form 10-K (filed 2018-02-13) ↗
FY2015Dec 31, 20157,279–Form 10-K (filed 2017-02-14) ↗

Cite this data

StockData. (2026). Amgen Other Intangible Assets ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/intang-accum-tot

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.